Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.

Nature cancer·2026
Same author

Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

Science translational medicine·2026
Same author

Targeting an RNA Editor to Impede H3K27M+ Pediatric Gliomas.

bioRxiv : the preprint server for biology·2026
Same author

Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

Communications medicine·2026
Same author

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study.

Nature genetics·2026
Same author

Pharmacologic DPP-4 inhibition promotes CD8<sup>+</sup> T cell metabolic fitness to enhance anti-tumor activity.

bioRxiv : the preprint server for biology·2026
Same journal

Large-scale discovery platform enables identification of peptides targeting drug-resistant candidiasis.

Cell reports methods·2026
Same journal

A computational method to design broad-spectrum T cell-inducing vaccines applied to Betacoronaviruses.

Cell reports methods·2026
Same journal

MalDeepSeq panel: A targeted ultra-deep sequencing approach to trace drug resistance markers in Plasmodium falciparum.

Cell reports methods·2026
Same journal

Induced pluripotent stem cell-derived macrophages enable broad modeling of human inflammasome signaling.

Cell reports methods·2026
Same journal

Rapid discovery of cell-surface glycosylation regulators using a lectin-based magnetic CRISPR screen.

Cell reports methods·2026
Same journal

A real-time FRET ubiquitin transfer assay for quantitative characterization of ternary complexes in targeted protein degradation.

Cell reports methods·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2025

Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
06:44

Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues

Published on: March 29, 2021

2.5K

Decomprolute is a benchmarking platform designed for multiomics-based tumor deconvolution.

Song Feng1, Anna Calinawan2, Pietro Pugliese3

  • 1Pacific Northwest National Laboratory, Seattle, WA, USA.

Cell Reports Methods
|February 27, 2024
PubMed
Summary
This summary is machine-generated.

Decomprolute is a new computational framework for comparing tumor deconvolution algorithms using proteogenomic data. This open-source platform enhances the analysis of cell types within solid tumors, improving rare cell identification.

Keywords:
CP: Cancer biologyCP: Systems biologyCPTACCWLcancerdeconvolutionproteogenomicsproteomics

More Related Videos

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.7K

Related Experiment Videos

Last Updated: Jul 2, 2025

Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
06:44

Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues

Published on: March 29, 2021

2.5K
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.7K

Area of Science:

  • Computational Biology and Bioinformatics
  • Proteogenomics
  • Cancer Research

Background:

  • Tumor deconvolution identifies cell types in solid tumors, but current methods primarily focus on gene expression (e.g., RNA sequencing) rather than protein levels.
  • Protein levels offer a more accurate representation of rare cell types compared to gene expression data.
  • A need exists for standardized tools to evaluate deconvolution algorithms across diverse, multiomic datasets.

Purpose of the Study:

  • To introduce Decomprolute, a Common Workflow Language (CWL) framework for comparing tumor deconvolution algorithms.
  • To facilitate the development, use, and reproducibility of multiomic deconvolution algorithms.
  • To enable benchmarking of algorithms using large-scale proteogenomic datasets.

Main Methods:

  • Developed Decomprolute as an open-source, containerized CWL framework.
  • Integrated large-scale multiomic datasets from the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
  • Included matched mRNA expression and proteomic data from thousands of tumors across multiple cancer types.

Main Results:

  • Established a fully open-source, containerized platform for benchmarking proteogenomic tumor deconvolution algorithms.
  • Enabled comparison of deconvolution algorithms across multiomic datasets, leveraging CPTAC data.
  • Facilitated reproducible analysis of tumor cellularity using both gene expression and protein abundance.

Conclusions:

  • Decomprolute provides a robust and reproducible platform for advancing multiomic tumor deconvolution.
  • The framework supports the development and validation of algorithms that utilize protein-level data for improved cell type identification.
  • This resource promotes standardized benchmarking in cancer proteogenomics research.